A new immunosuppressant: tacrolimus.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8977938.
- Also identified by PMC identifier 2398594.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tacrolimus is the new name for the Japanese immunosuppressant drug FK506. It blocks interleukin 2 transcription thereby inhibiting the CD4 Th-1 lymphocyte response to foreign antigens. It also selectively inhibits cytokine secretion of IL3, IL4 and interferon-gamma. It is metabolised by the cytochrome P-450 enzyme system. The results of two trials indicate that it is similar to cyclosporin in efficacy and toxicity.
Medical subject headings
- Graft Rejection
- Immunosuppressive Agents
- Tacrolimus